Analyst at finnCap Kept The InnovaDerma Plc (LON:IDP) “Corporate” Rating They’ve Had

June 19, 2018 - By Kenneth Lin

InnovaDerma Plc (LON:IDP) Rating Reaffirmed

The rating of InnovaDerma Plc (LON:IDP) shares were reaffirmed by analysts at finnCap. This was revealed to clients and investors in analysts note on 19 June.

The stock decreased 9.89% or GBX 11.87 during the last trading session, reaching GBX 108.13. About 310,182 shares traded or 85.54% up from the average. InnovaDerma PLC (LON:IDP) has 0.00% since June 19, 2017 and is . It has underperformed by 12.57% the S&P500.

InnovaDerma PLC, through its subsidiaries, engages in the research, manufacture, and marketing of clinically proven products in life sciences, beauty, and personal care products in Europe, the United States, Australasia, Asia, and Africa. The company has market cap of 15.55 million GBP. It offers a range of men's skincare products, including hand and body washes, hand creams, face washes, and face moisturizers under the Charles + Lee name; and tailored solutions under the Leimo name for hair loss comprising shampoos, conditioners, and laser technology treatments developed to combat male and female hair loss, alopecia, thinning hair. It has a 16.14 P/E ratio. The firm also provides tanning mousses, tanning gels, tanning oils, primers, moisturizers, and applicators under the Skinny Tan name; cosmetics under the Stevie K name; a medical device for premature ejaculation under the Prolong name; and haircare products for men and women to aid hair regrowth and hair thickening under the Roots name.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: